Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

A molecular signature of metastasis in primary solid tumors.

Ramaswamy S, Ross KN, Lander ES, Golub TR.

Nat Genet. 2003 Jan;33(1):49-54. Epub 2002 Dec 9.

PMID:
12469122
2.

Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors.

Casimiro S, Luis I, Fernandes A, Pires R, Pinto A, Gouveia AG, Francisco AF, Portela J, Correia L, Costa L.

Clin Exp Metastasis. 2012 Feb;29(2):155-64. doi: 10.1007/s10585-011-9438-0. Epub 2011 Nov 26.

PMID:
22120474
3.

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM.

BMC Cancer. 2007 Jan 3;7:2.

4.

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.

J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686.

5.

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J.

J Clin Invest. 2005 Jan;115(1):44-55.

6.

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ.

PLoS Med. 2010 Jul 13;7(7):e1000307. doi: 10.1371/journal.pmed.1000307.

7.

Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas.

Nambu Y, Iannettoni MD, Orringer MB, Beer DG.

Mol Carcinog. 1998 Dec;23(4):234-42.

PMID:
9869452
8.

Molecular targets in metastasis: lessons from genomic approaches.

Fingleton B.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):211-21. Review.

9.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
10.
11.

Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity.

Hsu YC, Chen HY, Yuan S, Yu SL, Lin CH, Wu G, Yang PC, Li KC.

BMC Med. 2013 Apr 16;11:106. doi: 10.1186/1741-7015-11-106.

12.

The molecular signature of metastases of human hepatocellular carcinoma.

Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW.

Oncology. 2005;69 Suppl 1:23-7. Epub 2005 Sep 19. Review.

PMID:
16210873
13.

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Tímár J, Gyorffy B, Rásó E.

Clin Exp Metastasis. 2010 Aug;27(6):371-87. doi: 10.1007/s10585-010-9307-2. Epub 2010 Feb 24. Review.

PMID:
20177751
14.

MicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat model.

Zaidi AH, Saldin LT, Kelly LA, Bergal L, Londono R, Kosovec JE, Komatsu Y, Kasi PM, Shetty AA, Keane TJ, Thakkar SJ, Huleihel L, Landreneau RJ, Badylak SF, Jobe BA.

PLoS One. 2015 Mar 31;10(3):e0122375. doi: 10.1371/journal.pone.0122375. eCollection 2015.

15.

Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population.

Fidler IJ, Kripke ML.

Nat Genet. 2003 May;34(1):23; author reply 25. No abstract available.

PMID:
12721548
16.

Gene signatures of progression and metastasis in renal cell cancer.

Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA.

Clin Cancer Res. 2005 Aug 15;11(16):5730-9.

17.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.

PMID:
24242678
18.

Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ.

Cancer Res. 2005 Oct 15;65(20):9155-8.

19.

Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.

Daves MH, Hilsenbeck SG, Lau CC, Man TK.

BMC Med Genomics. 2011 Jul 7;4:56. doi: 10.1186/1755-8794-4-56.

20.

Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.

Pentheroudakis G, Spector Y, Krikelis D, Kotoula V, Meiri E, Malamou-Mitsi V, Fountzilas G, Sanden M, Pavlidis N, Benjamin H, Aharonov R.

Clin Exp Metastasis. 2013 Apr;30(4):431-9. doi: 10.1007/s10585-012-9548-3. Epub 2012 Nov 4.

PMID:
23124598

Supplemental Content

Support Center